Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ridge Advisory
Seattle, Washington, USA
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Ridge Biotechnologies has launched AI-enabled platforms for precision enzyme/drug design, including NativeLink for site-specific conjugation and ProTrigger for protease-activated payload release; collaborations are ongoing, with at least one partnership focused on next-generation ADCs, but no clinical-stage data yet.
- Therapeutic areas
- OncologyOtherRare Diseases
- Modalities
- EnzymeSmall moleculeAntibody-drug conjugateAntibodyNucleic acid therapy (siRNA, ASOs, mRNA)PeptideRadiopharmaceuticalLipid nanoparticleProteinBiologic
- Industry
- Biotech
02
Partnerships
Undisclosed ADC-focused biotech partnersworking with leading biopharma and CDMOs (confidential)
Beyond the preview
Go deeper on Ridge Advisory.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ridge Advisory.